Krystal Biotech Reports Strong Q1 2026 Earnings, Eyes Upcoming Pipeline Catalysts
Krystal Biotech Inc. (NASDAQ: KRYS) announced its first‑quarter 2026 financial results on May 4, 2026, revealing a 26 ...
Read story →
Krystal Biotech Inc. (NASDAQ: KRYS) announced its first‑quarter 2026 financial results on May 4, 2026, revealing a 26 ...
Read story →
Latigo Biotherapeutics Inc. announced on July 17 2026 that it has filed a registration statement with the U.S. Securitie...
Read story →
In Oslo, the glow of digital signs is a daily backdrop—from the towering board at Oslo Central Station to the small pa...
Read story →
Powerfleet Inc. (NASDAQ: AIOT) announced its fiscal 2025 results on June 16, 2025, after a period of significant growth ...
Read story →
Elliott Investment Management and SVP Global recently acquired portions of Braskem’s debt, tightening the reins on the...
Read story →
On Monday, Kohl’s Corp. announced that former Foot Locker executive Elliott Rodgers will take the reins as chief opera...
Read story →
On May 29, 2026, Twist Bioscience’s chief legal officer, Dennis Cho, made headlines by liquidating nearly a quarter‑...
Read story →